Recruiting

Decision Support Tool for Patients With Advanced Breast Cancer

ClinicalTrials.gov IDNCT07635147

PhaseNA

Enrollment100

SponsorWeill Medical College of Cornell University

Age18 Years and older

SexALL

I'm interested View official listing

Conditions studied

Breast Cancer Metastatic, Advanced Breast Cancer, Stage 4 Breast Cancer, Stage IV (Metastatic) Breast Cancer

About this study

The goal of this pilot study is to understand and improve the shared decision-making process between people with advanced breast cancer and their providers regarding their care and treatment. As part of this study, the researchers will evaluate a decision support tool called COAST that was designed to support patients and providers in having meaningful conversations. The main questions it aims to answer are: 1. Can the COAST tool improve the quality of communication between patients and their oncology providers? 2. Is the COAST tool acceptable, appropriate, and easy to use at NYP-Weill Cornell Medicine, NYP-Brooklyn Methodist Hospital and NYP-Queens? Participants will be asked to fill out two surveys: one before they use the COAST tool and another about 2 - 4 weeks later. Some patients will also be invited for an interview.

Interventions

Behavioral: Decision Support Tool — The COAST decision support tool will be available in two formats: a booklet and a website. It will provide information about advanced breast cancer and the available treatment options. Participants will be guided through questions designed to clarify their goals and preferences, identify support needs, and concerns they may have.

Primary outcomes

Patient-reported acceptability of the COAST decision support tool (2-4 weeks after exposure to COAST)
Patient-reported appropriateness of the COAST decision support tool (2-4 weeks after exposure to COAST)
Provider-reported feasibility of the COAST decision support tool (At the conclusion of participant enrollment, approximately 1 month after the last patient is enrolled.)

Eligibility information

Inclusion Criteria: * Male or female 18 years and older * Diagnosis of Stage IV breast cancer * English, Spanish or Mandarin speaking Exclusion Criteria: * Early breast cancer * Individuals speaking languages other than English, Spanish, or Mandarin as their primary language

Study locations

NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York 11215 United States
NewYork-Presbyterian Medical Group Queens, Flushing, New York 11355 United States
NewYork-Presbyterian David H. Koch Center, New York, New York 10065 United States

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-10-21.